SemperVirens Venture Capital
SemperVirens Venture Capital is an ecosystem-driven early-stage venture firm investing in AI-native startups across healthtech, worktech, and fintech, deploying $300M+ across two fund vehicles, operating a cohort-based accelerator, and running a proprietary distribution platform connecting portfolio companies to 8,000+ enterprise buyers and 200+ executive advisors.
- Company typePrivate
- Founded2018
- HeadquartersSan Mateo, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What SemperVirens Venture Capital does
SemperVirens Venture Capital is an ecosystem-driven, early-stage venture capital firm that invests in AI-native startups across three thematic verticals: healthtech, worktech (workforce technology), and fintech. The firm is headquartered in San Mateo, California, operates as SemperVirens Ventures LLC, and reports more than $300 million raised cumulatively from institutional, strategic, and impact-oriented limited partners across two investment vehicles, including a $177 million healthcare and workforce technology fund closed in March 2025 with Sequoia and DPI reported among its LPs.
The firm's offering is structured as a platform-plus-modules architecture rather than a single fund product. Its core capital product is selective, stage-specific investment from accelerator through growth funds, with a published portfolio that includes six unicorns spanning Midi Health, Stepful, Spring Health, Rula, Multiverse, Rightway, Ashby, and Human Interest. On top of this, it operates the SemperVirens Accelerator — a curated cohort-of-four program for early-stage B2B startups that includes a built-in investment component — and the SemperVirens Ecosystem, a proprietary value-creation platform spanning Access (warm introductions to 8,000+ enterprise buyers and channel partners), Insights (portfolio benchmarking and buyer feedback), Amplification (go-to-market program design), and an Advisor Network of 200+ executive advisors including former CHROs, CPOs, and healthcare executives from companies such as IBM, ADP, Disney, Hilton, Visa, McKesson, and Walmart.
SemperVirens monetizes through standard venture-fund economics: recurring management fees on committed and invested capital, performance-based carried interest on fund returns, and capital returns on accelerator-stage investments. The firm does not publicly disclose management fee rates, fund minimums, or carry terms. Its go-to-market with portfolio companies emphasizes distribution-led value creation, with reported metrics of 5,000+ customer introductions and 1,000+ deals driven through partner distribution channels across the portfolio, and a stated $175M+ in directly influenced ARR. The team consists of approximately 14 named professionals led by two Managing Partners and two General Partners, supported by 200+ external executive advisors. The 2025 Year in Review reports top decile and top quartile performance across flagship funds and the return of over half of Fund I.
SemperVirens Venture Capital firmographics
Firmographics- Name
- SemperVirens Venture Capital
- Legal name
- SemperVirens Ventures LLC
- Website
- https://sempervirensvc.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- SemperVirens Venture Capital is an ecosystem-driven early-stage venture firm investing in AI-native startups across healthtech, worktech, and fintech, deploying $300M+ across two fund vehicles, operating a cohort-based accelerator, and running a proprietary distribution platform connecting portfolio companies to 8,000+ enterprise buyers and 200+ executive advisors.
- Ownership category
- akta.pro rank
SemperVirens Venture Capital industry classification
Industry- Product category
- Venture Capital
- akta.pro primary industry
- Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)
Keywords
Where SemperVirens Venture Capital is headquartered
LocationHeadquarters
- HQ city
- San Mateo
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
SemperVirens Venture Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Fund Management Fees: Recurring management fees on $300M+ raised from institutional, strategic, and impact-oriented LPs. Two distinct investment vehicles support companies by stage, from accelerator to growth funds.
- Carried Interest & Fund Returns: Performance-based returns from $177M healthcare and workforce tech fund (Fortune coverage, March 2025) with LPs including Sequoia. 2025 Year in Review noted returning over half of Fund I with top decile/quartile performance across flagship funds.
- Accelerator Program Investment Returns: Built-in investment component within the Accelerator program (curated cohort of four) supports participating companies and deepens long-term alignment, generating capital returns on accelerator-stage investments.
Go-to-market motion4 records
SemperVirens Venture Capital product offering
Product offeringCore offering
SemperVirens Venture Capital is an early-stage ecosystem venture capital firm that raises capital from institutional, strategic, and impact-oriented limited partners and invests it in AI-native startups across healthtech, worktech, and fintech. The firm supplements its fund vehicles with a curated Accelerator program (cohorts of four) and a proprietary Ecosystem platform providing enterprise introductions, advisory support, and channel partnerships to accelerate portfolio company go-to-market.
Product overview
SemperVirens Venture Capital is an ecosystem-driven venture capital firm delivering a platform-plus-modules architecture rather than a single product. Its core offering is selective, stage-specific capital deployed through its Venture Capital Fund(s), supplemented by the SemperVirens Accelerator program for early-stage B2B startups and the SemperVirens Ecosystem (an integrated value-creation platform spanning Access, Insights, Amplification, and an Advisor Network of 200+ executive advisors). Together, the Fund(s) provide investment capital, the Accelerator delivers hands-on distribution and GTM support with a built-in investment component, and the Ecosystem unlocks warm introductions, buyer feedback, and channel partnerships to accelerate portfolio companies across healthtech, worktech, and fintech.
Differentiator
Problem solved
Functional benefit
Brands
- SemperVirens Accelerator: The firm's venture capital accelerator program, helping early-stage B2B startups sharpen their distribution strategy, connect with industry leaders, and scale faster. Includes a built-in investment component.
Products and services
- SemperVirens Venture Capital Fund(s) Selective, stage-specific venture capital investment vehicles providing capital from accelerator stage through growth funds. The firm has raised $300M+ from institutional, strategic, and impact-oriented LPs and reports $175M+ in directly influenced ARR across the portfolio. Portfolio spans healthtech, worktech, and fintech categories.
- SemperVirens Accelerator VC accelerator program for early-stage B2B startups operating in small curated cohorts of four. Provides 1:1 strategic advisory, distribution-focused programming, executive events, access to a GTM network, and a built-in investment component. Supports companies at pre-revenue through early-pilot stages.
- SemperVirens Ecosystem Proprietary value-creation platform comprising four modules: Access (warm introductions to 8,000+ enterprise buyers and channel partners), Insights (benchmarks and buyer feedback), Amplification (go-to-market program design and channel partnerships), and an Advisor Network (200+ executive advisors across an Executive Advisory Board, Healthcare Advisory Board, and HR Venture Advisors).
Companies that use SemperVirens Venture Capital
Customer profileNamed customers14 records
Segments5 records
Ideal customer profiles3 records
SemperVirens Venture Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
SemperVirens Venture Capital partnerships and signals
Strategic signalScale indicators11 records
Recent moves7 records
Expansion highlights6 records
SemperVirens Venture Capital competitors and assessment
Company assessmentDirect peers
- Cowboy Ventures: Early-stage venture firm led by Aileen Lee (named in SemperVirens' ecosystem). Operates a similar stage-specific, thesis-driven model and is explicitly cited as a SemperVirens ecosystem partner.
- Forerunner Ventures:
- Define Ventures: Healthcare-focused venture firm that led 9amHealth's $26M Series B in which SemperVirens participated. Closest pure-play healthtech peer with similar stage and AI-driven thesis.
Broad incumbents
- General Catalyst: Large multi-stage venture firm with a deep healthtech franchise (analogous to SemperVirens' healthtech pillar) and a platform/value-creation model. Overlaps directly in healthcare AI, benefits, and workforce categories.
- Andreessen Horowitz (a16z): Largest U.S. venture platform with explicit Bio/Health and Work theses and a well-known platform playbook (enterprise buyer introductions, executive networks) that mirrors SemperVirens' Ecosystem strategy at much greater scale.
- Khosla Ventures: Long-standing venture firm with strong healthtech and AI portfolios and willingness to back bold, contrategory theses. Directly comparable in appetite for AI-native category-defining bets in complex markets.
- Bessemer Venture Partners: Multi-stage firm with strong healthcare and SaaS/cloud franchises and a published "anti-portfolio" track record. Comparable on stage range, healthcare exposure, and platform support for portfolio GTM.
- Lightspeed Venture Partners: Multi-stage firm with active healthtech, worktech, and consumer fintech investments. Comparable in stage range and AI-native appetite, and competes with SemperVirens on later-stage pro-rata rounds.
- Founders Fund: Peter Thiel-led multi-stage venture firm with significant healthtech and AI exposure. Comparable in willingness to back contrarian, category-defining AI bets in regulated and complex markets.
- GV (Google Ventures): Multi-stage corporate-affiliated venture firm with deep healthtech and AI expertise. Direct overlap with SemperVirens' healthcare and AI-native worktech investments (e.g., co-investor in Midi Health).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
SemperVirens Venture Capital social profiles
Digital presenceSemperVirens Venture Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
SemperVirens Venture Capital leadership team
Management profileNumber of profiles
Profiles14 records
SemperVirens Venture Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SemperVirens Venture Capital M&A and investment
M&A and investmentM&A
Investments77 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SemperVirens Venture Capital
What does SemperVirens Venture Capital do?
SemperVirens Venture Capital is an early-stage ecosystem venture capital firm that raises capital from institutional, strategic, and impact-oriented limited partners and invests it in AI-native startups across healthtech, worktech, and fintech. The firm supplements its fund vehicles with a curated Accelerator program (cohorts of four) and a proprietary Ecosystem platform providing enterprise introductions, advisory support, and channel partnerships to accelerate portfolio company go-to-market.
Is SemperVirens Venture Capital a public or private company?
SemperVirens Venture Capital is a private company. It is classified as venture growth investor backed and is currently operating.
When was SemperVirens Venture Capital founded?
SemperVirens Venture Capital was founded in 2018. It employs 1 to 10 people.
Where is SemperVirens Venture Capital based?
SemperVirens Venture Capital is headquartered in San Mateo, United States, in the North America region.
How does SemperVirens Venture Capital make money?
Three revenue lines are on record. Fund Management Fees are the primary driver. The others are carried Interest & Fund Returns and accelerator Program Investment Returns.
Who are SemperVirens Venture Capital's main competitors?
Direct peers on record are Cowboy Ventures, Forerunner Ventures and Define Ventures. Broad incumbents are General Catalyst, Andreessen Horowitz (a16z), Khosla Ventures, Bessemer Venture Partners, Lightspeed Venture Partners, Founders Fund and GV (Google Ventures).
Does SemperVirens Venture Capital have an API?
No public API is recorded for SemperVirens Venture Capital.
What industry is SemperVirens Venture Capital in?
SemperVirens Venture Capital's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAD, Sector-Focused Venture Capital (Vertical Specialists).